Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Outlook Wealth Advisors LLC

Outlook Wealth Advisors LLC boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 27.4% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 2,047 shares of the medical research company’s stock after acquiring an additional 440 shares during the quarter. Outlook Wealth Advisors LLC’s holdings in Agilent Technologies were worth $298,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Global Retirement Partners LLC lifted its stake in Agilent Technologies by 65.6% during the third quarter. Global Retirement Partners LLC now owns 1,446 shares of the medical research company’s stock valued at $161,000 after purchasing an additional 573 shares during the last quarter. DAVENPORT & Co LLC acquired a new stake in shares of Agilent Technologies during the 3rd quarter valued at $307,000. Occidental Asset Management LLC grew its stake in shares of Agilent Technologies by 3.0% in the 3rd quarter. Occidental Asset Management LLC now owns 18,872 shares of the medical research company’s stock valued at $2,110,000 after buying an additional 557 shares in the last quarter. Advisory Alpha LLC increased its holdings in shares of Agilent Technologies by 38.8% during the 3rd quarter. Advisory Alpha LLC now owns 2,670 shares of the medical research company’s stock valued at $299,000 after acquiring an additional 747 shares during the last quarter. Finally, Oak Thistle LLC acquired a new stake in Agilent Technologies in the 3rd quarter worth approximately $426,000.

Agilent Technologies Price Performance

A stock traded up $1.37 during trading on Friday, hitting $137.74. 754,945 shares of the stock traded hands, compared to its average volume of 1,245,651. The stock has a market cap of $40.36 billion, a price-to-earnings ratio of 32.78, a P/E/G ratio of 4.13 and a beta of 1.11. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $151.58. The company has a current ratio of 2.68, a quick ratio of 2.04 and a debt-to-equity ratio of 0.41. The company has a 50 day simple moving average of $141.59 and a 200 day simple moving average of $130.56.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.07. Agilent Technologies had a return on equity of 27.09% and a net margin of 18.35%. The business had revenue of $1.66 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the company earned $1.37 EPS. Agilent Technologies’s revenue for the quarter was down 5.5% on a year-over-year basis. Equities analysts expect that Agilent Technologies, Inc. will post 5.5 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 24th. Investors of record on Tuesday, April 2nd were issued a $0.236 dividend. The ex-dividend date was Monday, April 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.69%. Agilent Technologies’s dividend payout ratio is 22.38%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. UBS Group upped their price objective on shares of Agilent Technologies from $130.00 to $155.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. Barclays boosted their price objective on Agilent Technologies from $125.00 to $135.00 and gave the stock an “underweight” rating in a research report on Wednesday, April 10th. Oppenheimer lifted their price target on Agilent Technologies from $67.00 to $90.00 and gave the stock an “outperform” rating in a research report on Tuesday, March 26th. Citigroup raised their price objective on shares of Agilent Technologies from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 28th. Finally, Evercore ISI upped their target price on shares of Agilent Technologies from $132.00 to $145.00 and gave the company an “in-line” rating in a research note on Thursday, April 4th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $141.29.

Insider Buying and Selling

In other news, Director Heidi Fields sold 1,658 shares of the business’s stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $144.34, for a total transaction of $239,315.72. Following the completion of the sale, the director now owns 54,976 shares in the company, valued at $7,935,235.84. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other Agilent Technologies news, VP Rodney Gonsalves sold 4,828 shares of Agilent Technologies stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $149.00, for a total transaction of $719,372.00. Following the transaction, the vice president now directly owns 21,329 shares in the company, valued at $3,178,021. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Heidi Fields sold 1,658 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $144.34, for a total value of $239,315.72. Following the completion of the transaction, the director now directly owns 54,976 shares of the company’s stock, valued at $7,935,235.84. The disclosure for this sale can be found here. Insiders have sold a total of 61,610 shares of company stock worth $9,220,333 in the last 90 days.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.